At a Glance
| Citicoline | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 250–1000 mg | 1000–2000 mg |
| Total Duration | 5.5–8.5 hrs | 0.5–1.5 hrs |
| Routes | oral | Oral |
| Effects | 15 documented | 4 documented |
Citicoline, a Nootropic, and D-Serine, a Nootropic, NMDA enhancer, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Citicoline is classified as a Nootropic while D-Serine is a Nootropic, NMDA enhancer, meaning they approach altered states through different pharmacological mechanisms. They share 1 documented effects in common, with 14 effects unique to Citicoline and 3 unique to D-Serine. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Citicoline | D-Serine | |
|---|---|---|
| Class | Nootropic | Nootropic, NMDA enhancer |
| Common Dose (oral) | 250–1000 mg | 1000–2000 mg |
| Total Duration | 5.5–8.5 hrs | 0.5–1.5 hrs |
| Routes | oral | Oral |
| Effects | 15 documented | 4 documented |
| Level | Citicoline | D-Serine |
|---|---|---|
| Threshold | 50 mg | — mg |
| Light | 100–250 mg | 500–1000 mg |
| Common | 250–1000 mg | 1000–2000 mg |
| Strong | 1000–2000 mg | 2000–4000 mg |
| Heavy | 2000 mg | 8000 mg |
Citicoline
D-Serine
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.